SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST (1490)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-glomerular basement membrane (GBM) antibodies (K011348 | K011348) HIGH
Effective Date: 2001-06-22

Other General Immunology Devices:

Medical DeviceComplexity
Pharmacia CAP System IgE FEIAView Complexity
Luminex 200 Integrated SystemView Complexity
Cogent Diagnostics AUTOSTAT II Anti-PR-3 c-ANCA (IgG) ELISAView Complexity
Roche Diagnostics Cobas Integra 400View Complexity
The Binding Site SPAplusView Complexity
Roche Diagnostics Cobas Integra 700View Complexity
AXIS-SHIELD DIASTAT ANTI-CCPView Complexity
EUROIMMUN Anti-Glutamate receptor (type NMDA) IFAView Complexity
Apotex Scl-70 ELISAView Complexity
Beckman Synchron CX 5View Complexity